ULTRA™ Duramune® vaccines are the next step in protection and comfort — allowing us to offer the best medicine for our patients and their owners.
- The first-ever 0.5 mL canine vaccine line
- Designed to offer a more comfortable vaccine experience with 50% less volume than most vaccines
- Made with exclusive PureFil™ Technology, designed to decrease vaccine reactions by reducing extraneous proteins and cellular debris
- Passes identical high-potency tests as Duramune® — a brand that’s been trusted for more than 30 years
- Combinations more closely aligned with American Animal Hospital Association (AAHA) Canine Vaccine Guidelines
Boehringer Ingelheim Vetmedica, Inc. (BIVI), is committed to ongoing improvement and innovation with one focus — delivering best medicine. And delivering on that commitment through exclusive PureFil™ Technology. The continuous evolution of PureFil™ Technology — designed to decrease vaccine reactions by reducing extraneous proteins and cellular debris — has helped create ULTRA™ Duramune
